Solara Active Pharma Sciences · NSE: SOLARA · BSE: 541540
Q1 FY19 results · Apr–Jun 2018
Solara Active Pharma Sciences reported revenue from operations of ₹302.81 crore and net profit of ₹2.58 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 302.81 | — | — | — | — |
| Other income | 0.48 | — | — | — | — |
| Total income | 303.30 | — | — | — | — |
| Profit before tax | 9.26 | — | — | — | — |
| Net profit for the period | 2.58 | — | — | — | — |
| Attributable to shareholders of the company | 2.56 | — | — | — | — |
| EPS, basic (₹) | 0.23 | — | — | — | — |
| Net margin (%) | 0.9 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 302.81 | — | — | — | — |
| Other income | 0.43 | — | — | — | — |
| Total income | 303.24 | — | — | — | — |
| Profit before tax | 9.66 | — | — | — | — |
| Net profit for the period | 2.98 | — | — | — | — |
| EPS, basic (₹) | 0.39 | — | — | — | — |
| Net margin (%) | 1.0 | — | — |
Consolidated
- Filed with BSE
- 04 Aug 2018, 13:33 IST
- Board meeting
- 03 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Aug 2018, 13:33 IST
- Board meeting
- 03 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE